Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have potential to transform health outcomes for persons with bipolar disorder, schizophrenia, major depressive disorder and other serious mental illnesses by lengthening healthspan and reducing excess and premature mortality
For many, starting a GLP-1 medication like Ozempic (semaglutide) represents a major turning point in their medical weight loss journey
Focus on Your Mental Health There is some concern that GLP-1s can lead to increased mental health issues like depression and suicidal thoughts
Regular physical activity throughout the week aiming for at least 150 minutes of moderate-intensity exercise as recommended by NHS guidelines supports overall gastrointestinal function
GLP2, a new era of dual-targeted treatment for diabetes and obesity: A mini-review
"You have to think about this as chronic disease management, not responding to a TikTok trend." Rekha Kumar, M.D., Found's chief medical officer and a specialist in obesity medicine, said that the increased attention and demand for drugs like Ozempic and Wegovy are leading payers to look far more closely at prescriptions and deny coverage more frequently